[144] LABCORP HOLDINGS INC. SEC Filing

Rhea-AI Filing Summary

LH filed a Form 144 notice for a proposed sale of 7,009 shares of common stock on the NYSE, with an approximate sale date of 10/31/2025. The filing lists an aggregate market value of $1,782,273.05 for the proposed sale and names Fidelity Brokerage Services LLC as broker. Shares outstanding were 82,900,000.

The shares to be sold were acquired through restricted stock vesting from 2018 through 2025, including tranches such as 1,263 (02/07/2018), 1,227 (02/12/2020), 986 (02/04/2021), 947 (02/07/2024), and 944 (02/06/2025), summing to 7,009 shares.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7009	1782273.05	82900000	10/31/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/07/2018	Restricted Stock Vesting	Issuer			1263	02/07/2018	Compensation
Common	02/12/2019	Restricted Stock Vesting	Issuer			129	02/12/2019	Compensation
Common	02/12/2020	Restricted Stock Vesting	Issuer			1227	02/12/2020	Compensation
Common	02/04/2021	Restricted Stock Vesting	Issuer			986	02/04/2021	Compensation
Common	02/02/2022	Restricted Stock Vesting	Issuer			771	02/02/2022	Compensation
Common	02/11/2023	Restricted Stock Vesting	Issuer			742	02/11/2023	Compensation
Common	02/07/2024	Restricted Stock Vesting	Issuer			947	02/07/2024	Compensation
Common	02/06/2025	Restricted Stock Vesting	Issuer			944	02/06/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)